Table of Contents
ISRN Oncology
Volume 2012 (2012), Article ID 242850, 7 pages
http://dx.doi.org/10.5402/2012/242850
Clinical Study

Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer

1Department of Oncology, Wayne State University and Karmanos Cancer Center, Detroit, MI 48201, USA
2Division of Hematology/Oncology, Henry Ford Health System, Detroit, MI 48202, USA
3Department of Medicine, Section of Oncology, John D. Dingell VA Medical Center, Detroit, MI 48201, USA

Received 18 March 2012; Accepted 9 April 2012

Academic Editors: S. Honoré and B. Luber

Copyright © 2012 Shin Ogita et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Shin Ogita, Sheela Tejwani, Lance Heilbrun, et al., “Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer,” ISRN Oncology, vol. 2012, Article ID 242850, 7 pages, 2012. doi:10.5402/2012/242850